Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will generic nurtec be available?Trulicity generic when available dulaglutide patent expiration?Roflumilast 500 mcg price?Breztri aerosphere generic name?Entresto generic availability date?
See the DrugPatentWatch profile for Nurtec
Nurtec ODT Global Sales in 2023 In 2023, Nurtec ODT (rimegepant) generated approximately $696 million in global net sales [1]. This figure represents a notable increase from the $625.1 million reported in 2022 [2]. How Nurtec ODT's Performance Compares Nurtec ODT's sales in 2023 indicate continued growth in the market for acute treatment of migraine [1]. While specific comparative sales data against all competitors for 2023 is not detailed here, the drug's performance is a key indicator of its market presence. What Factors Drive Nurtec ODT Sales? The sales of Nurtec ODT are influenced by its efficacy in treating both the pain and most common symptoms of migraine attacks, as well as its non-opioid, non-ergot formulation [3]. The drug's availability in an orally disintegrating tablet (ODT) form offers a convenient administration option for patients [3]. When Does Nurtec ODT's Patent Protection End? Patent expiry dates are crucial for understanding future market competition. DrugPatentWatch.com tracks patent information for medications like Nurtec ODT. Specific patent expiry timelines and any potential challenges can be found by consulting resources that monitor intellectual property for pharmaceuticals [4]. What is Nurtec ODT Used For? Nurtec ODT is approved for the acute treatment of migraine with or without aura in adults [3]. It functions as a calcitonin gene-related peptide (CGRP) receptor antagonist [3]. Sources 1. Pfizer Inc. (2024, February 1). Pfizer Reports Fourth Quarter and Full-Year 2023 Results. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-fourth-quarter-and-full-year-2023-results 2. Pfizer Inc. (2023, February 2). Pfizer Reports Fourth Quarter and Full-Year 2022 Results. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-fourth-quarter-and-full-year-2022-results 3. Nurtec ODT. (n.d.). Nurtec ODT® (rimegepant) tablets [Prescribing Information]. Pfizer Inc. 4. DrugPatentWatch.com. (n.d.). https://drugpatentwatch.com/
Other Questions About Nurtec :